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Materials and Methods 
Experimental protocol 
The experiment was performed as a single dose parallel study with 64 female turkeys. 
Thirty-two animals received an SC bolus of 6 mg/kg BW GAM at the neck. The other 32 
were given an oral bolus at the same dose. Blood (1 mL) was collected from 5 animals per 
group by venipuncture from the leg vein at different time points before (time 0) and post 
administration (p.a.; 0.08, 0.25, 0.5, 0.75, 1, 2, 4, 6, 8, 10 and 12 hours, once daily from the 
second day until the tenth and once on day 12 and 14). Plasma was collected and stored at  
≤ -15 °C until analysis. From each group, 4 animals were sacrificed to collect lung tissue at 
various time points (day 1, 5, 10, 15, 20, 30, 40 and 50 p.a.). One lung of each animal was 
collected for GAM concentration analysis and stored at ≤ -15 °C until analysis. 
 
GAM analysis 
Quantitation of GAM in plasma and lung were carried out using a liquid chromatography-
tandem mass spectometry (LC-MS/MS) method. 
 
PK and Statistical analysis 
The PK parameters were analyzed using WinNonlin, version 6.3.0 (Pharsight). A non-
compartmental model was used to determine AUClast, AUCinf, kel, T1/2 el (expressed as the 
harmonic mean), Vd, Cl, C0, Tmax and Cmax.  
Results 
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Discussion and Conclusion 
There are significant differences between SC and PO administration of GAM for AUClast, AUCinf, tmax and Cmax in plasma. Volume of distribution and clearance were corrected for 
the relative oral bioavailability (Frel is 0.25). The Vd is very high and even higher than in other species (24.9 L/kg, 27.8 L/kg and 31.03 L/kg for respectively cattle, broiler 
chickens and pigs). This leads to a high penetration in tissue. This is confirmed by the lung tissue samples. The concentration in the lung is up to 80 times higher 
 than in plasma. After oral bolus administration, the concentrations were lower than after SC administration. 
 We can conclude that there is a rapid absorption of GAM after SC and PO administration with a high penetration into lung tissue, 
 which is of major importance for treatment of respiratory diseases, such as ORT infections. 
Fig. 1. Mean plasma concentration-time profiles of GAM after SC (n=5) and PO (n=5) 
bolus administration of 6 mg/kg BW in turkeys 
Table 1. Pharmacokinetic parameters for GAM in turkey plasma and lung tissue after 
SC and PO bolus administration of 6 mg/kg BW, presented as mean (SD) 
A: harmonic mean 
Introduction 
Gamithromycin (GAM) is a 15-membered semi-synthetic macrolide, used in the treatment of Bovine Respiratory Disease complex. At the moment, GAM is only registered for 
use in cattle, therefore, pharmacokinetic and pharmacodynamic data in most other animal species are lacking. 
It has been demonstrated that GAM could have a positive effect on respiratory disorders in turkeys, for instance in infection of Ornithobacterium rhinotracheale (ORT) in 
turkey poults (unpublished data). For a better understanding of the pharmacodynamic properties of GAM against ORT, pharmacokinetic data are needed in this animal 
species. Therefore, the aim of this study was to investigate several pharmacokinetic parameters of GAM in turkey plasma and the target organ, lung, after oral (PO) as well as 
subcutaneous (SC) administration.  
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Fig. 2. Mean plasma and lung concentration-time 
profiles of GAM after SC and PO bolus administration 
of 6 mg/kg BW in turkeys 
Table 2. Lung/plasma concentration ratios of GAM at 
various time points in turkeys after SC and PO bolus 
administration of 6 mg/kg BW 
Parameter Units 
Plasma Lung 
SC PO SC PO 
AUClast h.µg/mL 
5.140  
(1.623) 
1.284   
(0.718) 
452.02 165.63 
AUCinf h.µg/mL 
6.847  
(2.831) 
2.173   
(1.302) 
466.85 180.75 
kel /h 
0.020  
(0.0069) 
0.023  
(0.20) 
0.0075 0.0116 
t1/2 el h 34.91 
A 29.72 A 92.56 59.78 
Vd L/kg 
53.69  
(19.66) 
50.84  
(28.35) 
- - 
Cl L/h.kg 
1.02  
(0.47) 
0.95 
(0.53) 
- - 
Tmax h 
0.08  
(0.00) 
0.85  
(0.22) 
24.0 24.0 
Cmax µg/mL 
0.886  
(0.413) 
0.087   
(0.099) 
3.656 2.22 
No plasma concentrations were detected after 10 and 15 days for PO and SC administration, respectively. 
